Ampio Pharmaceuticals (NYSE:AMPE) Earns Sell Rating from Analysts at StockNews.com

Research analysts at StockNews.com began coverage on shares of Ampio Pharmaceuticals (NYSE:AMPE) in a research report issued on Tuesday. The firm set a “sell” rating on the stock.

Ampio Pharmaceuticals Price Performance

Shares of NYSE AMPE opened at $0.00 on Tuesday. The firm has a market capitalization of $2,497.00, a price-to-earnings ratio of 0.00 and a beta of 3.67. Ampio Pharmaceuticals has a fifty-two week low of $0.00 and a fifty-two week high of $7.47.

About Ampio Pharmaceuticals

Ampio Pharmaceuticals, Inc, a biopharmaceutical company, develops therapies for the treatment of osteoarthritis of the knee (OAK) in the United States. It develops OA-201, a small molecule formulation for the treatment of OAK pain. The company is headquartered in Englewood, Colorado.